
Regeneron and Sanofi have received approval for its eczema treatment, Dupixent, by the FDA. The treatment will be the first …

NHS England has identified 10 items that it believes can cut £128 million from its yearly bill. The 10 items …

Alexion had been left in leadership limbo for the beginning of the year, as former CEO and CFO left under …
Kite Pharma has revealed the addition of celebrated bioscientist and researcher Dr Owen N. Witte to its Board of Directors, …

Mylan continues to cut away Meda’s US operations to “reduce redundancy” – the latest sees Mylan closing an Illinois-based facility, …

Ex-Valeant CEO Michael Pearson is suing his former company over its failure to deliver three million shares he claims he …

The EMA’s Committee for Medicinal Products for Human Use (CHMP) has called for the suspension of 331 drugs due to …

The research organisation ABPI, alongside RAND Europe, has released a ‘snapshot’ of data, from its Disclosure UK database, from January …
Leading UK contract analytical chemistry provider, Butterworth Laboratories Ltd, is delighted to announce it has secured an additional facility in …

Researchers from the University of Bristol and NHS Blood and Transplant have managed to perfect a technique whereby it is …

Bone Therapeutics, a bone cell therapy company focusing on orthopaedics and bone disease, has appointed Miguel Forte to the position …

Following on from the positive opinion given to Xeljanz in January of this year, Pfizer’s drug has now been given …

Infectex, a Russian portfolio company of Maxwell Biotech Venture Fund, announced that it had found positive results from its latest …

AstraZeneca has been boosted by the news that its drug, Tagrisso, has become its first drug to be approved under …

One million people die from fake drugs every year, with the worst continent being Africa where a suspected 200,000 die …

Merck KGaA and Pfizer have won approval for the fourth immunotherapy treatment to enter the market, with an indication in …

Eli Lilly’s latest press release indicated that it would be spending $850 million in developing its worldwide US operations, particularly …

With the weekend on the horizon and a new issue of Pharmafocus hitting press, we review the most read, shared …

Cancer Research UK has revealed a £10 million investment into PRECISION-Panc, a pancreatic cancer-focused project which aims to improve patient …

This report provides an analysis of the Australian pharmaceutical and biopharmaceutical industry through the lens of patents. By using the …